GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Gross Margin %
中文

Global Cord Blood (Global Cord Blood) Gross Margin % : 85.88% (As of Mar. 2022)


View and export this data going back to 2007. Start your Free Trial

What is Global Cord Blood Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Global Cord Blood's Gross Profit for the three months ended in Mar. 2022 was $40.2 Mil. Global Cord Blood's Revenue for the three months ended in Mar. 2022 was $46.8 Mil. Therefore, Global Cord Blood's Gross Margin % for the quarter that ended in Mar. 2022 was 85.88%.


The historical rank and industry rank for Global Cord Blood's Gross Margin % or its related term are showing as below:


CORBF's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 45.595
* Ranked among companies with meaningful Gross Margin % only.

Global Cord Blood had a gross margin of 85.88% for the quarter that ended in Mar. 2022 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Global Cord Blood was 0.00% per year.


Global Cord Blood Gross Margin % Historical Data

The historical data trend for Global Cord Blood's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Gross Margin % Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.63 81.15 84.52 84.57 85.26

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.81 84.82 85.27 85.09 85.88

Competitive Comparison of Global Cord Blood's Gross Margin %

For the Diagnostics & Research subindustry, Global Cord Blood's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Cord Blood's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Gross Margin % falls into.



Global Cord Blood Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Global Cord Blood's Gross Margin for the fiscal year that ended in Mar. 2022 is calculated as

Gross Margin % (A: Mar. 2022 )=Gross Profit (A: Mar. 2022 ) / Revenue (A: Mar. 2022 )
=167.1 / 195.955
=(Revenue - Cost of Goods Sold) / Revenue
=(195.955 - 28.892) / 195.955
=85.26 %

Global Cord Blood's Gross Margin for the quarter that ended in Mar. 2022 is calculated as


Gross Margin % (Q: Mar. 2022 )=Gross Profit (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=40.2 / 46.844
=(Revenue - Cost of Goods Sold) / Revenue
=(46.844 - 6.616) / 46.844
=85.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Global Cord Blood  (OTCPK:CORBF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Global Cord Blood had a gross margin of 85.88% for the quarter that ended in Mar. 2022 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Global Cord Blood Gross Margin % Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Cord Blood (Global Cord Blood) Business Description

Traded in Other Exchanges
N/A
Address
1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Executives
Kent C Mccarthy 10 percent owner, other: Mbr 13(d) grp own 10% plus 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010 other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010 10 percent owner, other: Member of 13(d) group owning m 7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc 10 percent owner, other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p. other: 13(d) group owning > 10% 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc other: Member of the group 13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd other: Member of the group 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p. 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205

Global Cord Blood (Global Cord Blood) Headlines

From GuruFocus

Global Cord Blood Corporation Files Annual Report on Form 20-F

By PRNewswire PRNewswire 08-16-2022